Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Nuffield Department of Orthopaedic, Rheumatology and Musculoskeletal Sciences (NDORMS) is delighted to announce that Professor Jonathan Rees has been appointed as the new Director of the Botnar Research Institute

Horizontal portrait of Jonathan Rees

Professor Rees will take up the role in August 2021 from Professor Andrew Carr, also the Head of Department at NDORMS, who said: “Prof Jonny Rees is an outstanding clinician scientist with a strong track record in research that has positively influenced the care of patients with musculoskeletal disorders. His vision and energy will be of enormous value as the new Marcela wing of the Botnar opens and we expand our research and teaching programmes.” 

Prof Rees graduated from St Mary's Hospital Medical School, London, then trained in orthopaedics in Oxford. He was appointed Clinical Lecturer to NDORMS in 2004 and then University Lecturer in 2005. He continued as a shoulder and elbow surgeon, while teaching, training and running a musculoskeletal research programme before becoming Professor of Orthopaedic Surgery and Musculoskeletal Science in 2014. He is the incoming President of the British Elbow and Shoulder Society, and has recently been selected to be an NIHR Senior Investigator. Besides his university and national work, he continues to work as a Consultant Orthopaedic Shoulder Surgeon at the Nuffield Orthopaedic Centre (NOC). 

“I am thrilled to be taking over the Directorship of the Botnar at such an exciting time,” said Prof Rees. “Exciting because the new Marcela wing of the Botnar is nearing completion, and exciting because we seem to be exiting the pandemic and I will be able to welcome all our staff and students back to the Institute. The last 12 years under the Directorship of Andy Carr has seen a step change in musculoskeletal research capacity at the Botnar and I look forward to working with all our brilliant staff to make the next decade even more successful.” 

Similar stories

Study finds marked differences in the use of ankle replacements across six countries

A new study published in Foot and Ankle International reviews the use of ankle replacements across 6 countries to predict why there is a variance in their use, and to determine how far current demands are being met.

NDORMS wins government funding to develop AI for bone health

A state-of-the-art method that uses artificial intelligence to check bone health and reduce fracture risk has been successful in the latest round of the Artificial Intelligence in Health and Care Award.

Celebrating World Clubfoot Day

More than 30,000 children in Africa are born with clubfoot each year. With treatment simply not available where they live, many thousands of these children get no treatment and end up with severe deformities that make it hard and very painful to walk.

New centre aims to help companies conduct more efficient trials

A new clinical therapeutics centre has been set up by the University of Oxford to help life sciences companies identify interventions that have the greatest potential to deliver patient benefit, and so bring down the cost of early phase clinical trials.

Understanding the first wave of COVID-19 and implications for tackling the ongoing pandemic: evidence from 5.5 million people from Catalonia, Spain

Health outcomes during the first wave of COVID-19 in Catalonia, Spain, have been described in detail in a study published by Nature Communications.

A more tailored approach to treating psoriatic arthritis

Dr Laura Coates has been awarded £1.8M from the National Institute for Health Research (NIHR) to explore the potential for precision medicine in the choice of biologics to reduce inflammation and pain in psoriatic arthritis.